DocuSign, Inc. (NASDAQ:DOCU) Shares Purchased by Versor Investments LP

Versor Investments LP raised its stake in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 346.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,545 shares of the company's stock after buying an additional 29,136 shares during the quarter. DocuSign comprises approximately 0.5% of Versor Investments LP's holdings, making the stock its 22nd largest position. Versor Investments LP's holdings in DocuSign were worth $2,232,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Assenagon Asset Management S.A. increased its stake in DocuSign by 321.3% in the 3rd quarter. Assenagon Asset Management S.A. now owns 214,877 shares of the company's stock worth $9,025,000 after acquiring an additional 163,875 shares during the last quarter. Executive Wealth Management LLC purchased a new stake in DocuSign during the third quarter valued at $1,000,000. SG Americas Securities LLC lifted its position in DocuSign by 93.1% during the fourth quarter. SG Americas Securities LLC now owns 78,423 shares of the company's stock valued at $4,662,000 after purchasing an additional 37,801 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of DocuSign by 77.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,215,650 shares of the company's stock worth $51,057,000 after buying an additional 531,682 shares in the last quarter. Finally, Duality Advisers LP bought a new stake in shares of DocuSign in the 3rd quarter worth about $1,686,000. Hedge funds and other institutional investors own 77.64% of the company's stock.

Insider Buying and Selling at DocuSign

In other news, Director Peter Solvik sold 15,000 shares of the stock in a transaction that occurred on Tuesday, April 9th. The shares were sold at an average price of $60.00, for a total transaction of $900,000.00. Following the transaction, the director now directly owns 783 shares in the company, valued at $46,980. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other DocuSign news, insider James P. Shaughnessy sold 1,800 shares of the stock in a transaction dated Tuesday, April 2nd. The shares were sold at an average price of $57.50, for a total transaction of $103,500.00. Following the completion of the sale, the insider now directly owns 46,503 shares of the company's stock, valued at $2,673,922.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Peter Solvik sold 15,000 shares of the stock in a transaction that occurred on Tuesday, April 9th. The shares were sold at an average price of $60.00, for a total transaction of $900,000.00. Following the sale, the director now directly owns 783 shares of the company's stock, valued at approximately $46,980. The disclosure for this sale can be found here. In the last quarter, insiders have sold 55,277 shares of company stock valued at $3,159,756. Company insiders own 1.66% of the company's stock.

DocuSign Price Performance

DOCU stock traded up $0.75 during mid-day trading on Friday, reaching $58.03. The company had a trading volume of 988,430 shares, compared to its average volume of 1,400,045. DocuSign, Inc. has a 12 month low of $38.11 and a 12 month high of $64.76. The company has a market capitalization of $11.92 billion, a PE ratio of 161.20, a price-to-earnings-growth ratio of 4.95 and a beta of 0.88. The firm has a 50 day moving average of $57.76 and a 200 day moving average of $53.81.

DocuSign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings results on Thursday, March 7th. The company reported $0.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.09 by $0.06. The business had revenue of $712.39 million for the quarter, compared to the consensus estimate of $698.05 million. DocuSign had a return on equity of 13.91% and a net margin of 2.68%. Analysts anticipate that DocuSign, Inc. will post 0.87 EPS for the current year.

Analyst Ratings Changes

Several research firms recently commented on DOCU. Morgan Stanley upgraded DocuSign from an "underweight" rating to an "equal weight" rating and lifted their price target for the stock from $49.00 to $64.00 in a research report on Tuesday, January 16th. Needham & Company LLC reissued a "hold" rating on shares of DocuSign in a research report on Friday, April 12th. UBS Group upgraded DocuSign from a "sell" rating to a "neutral" rating and raised their price target for the stock from $48.00 to $62.00 in a research report on Friday, April 12th. Royal Bank of Canada reiterated a "sector perform" rating and set a $59.00 price objective on shares of DocuSign in a research report on Friday, April 12th. Finally, JMP Securities restated a "market outperform" rating and issued a $84.00 target price on shares of DocuSign in a report on Friday, April 12th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, DocuSign presently has an average rating of "Hold" and an average target price of $60.25.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.